EKF Diagnostics (LON:EKF) Hits New 12-Month Low – Here’s Why

EKF Diagnostics Holdings plc (LON:EKFGet Free Report) shares reached a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 19.10 ($0.25) and last traded at GBX 19.30 ($0.25), with a volume of 350777 shares changing hands. The stock had previously closed at GBX 19.50 ($0.25).

EKF Diagnostics Stock Down 1.0 %

The company has a market cap of £85.78 million, a PE ratio of 17.96 and a beta of 0.57. The company’s 50 day moving average is GBX 24.19 and its 200 day moving average is GBX 26.24. The company has a current ratio of 4.60, a quick ratio of 1.77 and a debt-to-equity ratio of 0.34.

About EKF Diagnostics

(Get Free Report)

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Featured Articles

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.